This study examined the relation of adiponectin levels alone or normalized by leptin to metabolic risk factors for cardiovascular disease including markers of atherogenic dyslipidemia (levels of plasma triglyceride and HDL cholesterol and ratios of plasma triglyceride/HDL cholesterol) and insulin resistance (levels of HOMA2-IR) in men. The gene discussed is ADIPOQ; the disease is cardiovascular disorder.